+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Human Microbiome Therapeutics"

Global Human Microbiome Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Human Microbiome Therapeutics Market 2023-2027

  • Report
  • June 2023
  • 159 Pages
  • Global
From
From
From
From
Human Microbiome Market Report 2023-2033 - Product Thumbnail Image

Human Microbiome Market Report 2023-2033

  • Report
  • January 2023
  • 281 Pages
  • Global
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

The Human Microbiome Therapeutics market is a subset of the biopharmaceuticals industry that focuses on the development of treatments and therapies that target the human microbiome. The human microbiome is the collection of microorganisms that live in and on the human body, and is increasingly being recognized as an important factor in human health. The Human Microbiome Therapeutics market is focused on developing treatments and therapies that target the microbiome, such as probiotics, prebiotics, and fecal microbiota transplants. These treatments are used to treat a variety of conditions, including gastrointestinal disorders, metabolic disorders, and autoimmune diseases. Companies in the Human Microbiome Therapeutics market include Seres Therapeutics, Second Genome, Enterome Bioscience, and Rebiotix. Show Less Read more